| Marketable Securities |
Note
7. Marketable Securities
At
December 31, 2025, the Company’s debt and equity securities, including approximately $996,000 classified in cash and cash equivalents,
consisted of the following:
Schedule of Marketable of Securities
| | |
Amortized Cost | | |
Unrealized Gains | | |
Unrealized Losses | | |
Aggregate Fair Value | |
| Government and agency securities | |
$ | 5,225,930 | | |
$ | 2,073 | | |
$ | - | | |
$ | 5,228,003 | |
| Equity securities | |
| | | |
| | | |
| | | |
| 1,883,729 | |
| | |
| | | |
| | | |
| | | |
$ | 7,111,732 | |
| | |
| | | |
| | | |
| | | |
| | |
| Included in cash and cash equivalents | |
| | | |
| | | |
| | | |
$ | 1,415,346 | |
| Included in marketable securities | |
| | | |
| | | |
| | | |
$ | 5,696,386 | |
At
December 31, 2024, the Company’s debt and equity securities, including approximately $2,542,000 classified in cash and cash equivalents,
consisted of the following:
| |
|
Amortized
Cost |
|
|
Unrealized
Gains |
|
|
Unrealized
Losses |
|
|
Aggregate
Fair
Value |
|
| Government
and agency securities |
|
$ |
11,461,885 |
|
|
$ |
3,270 |
|
|
$ |
(1,670 |
) |
|
$ |
11,463,485 |
|
| Corporate
bonds |
|
|
1,845,226 |
|
|
|
953 |
|
|
|
(944 |
) |
|
|
1,845,235 |
|
| Debt
securities |
|
$ |
13,307,111 |
|
|
$ |
4,223 |
|
|
$ |
(2,614 |
) |
|
|
13,308,720 |
|
| Equity
securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,429,576 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
19,738,296 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Included
in cash and cash equivalents |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,236,312 |
|
| Included
in marketable securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
16,501,984 |
|
The
contractual maturities of the Company’s debt securities, including approximately $996,000 classified in cash and cash equivalents,
are as follows:
Schedule of Contractual Maturities Investments of Marketable Securities
| | |
As of December 31, 2025 | |
| Due within one year | |
$ | 5,228,003 | |
|